Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC

NCT04691947 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID-19 Vaccine

Interventions

BIOLOGICAL: ERUCOV-VAC
OTHER: Placebo Vaccine

Sponsor

Health Institutes of Turkey

Collaborators

[object Object]